why am i still hungry on glp 1 GLP-1? Causes & What To Do The Ultimate Guide to GLP-1:

We discuss the science...

The company has acquired a European competitor, Zava, which already has 1.3 million customers for a range of productsincluding some obesity treatmentsin the UK, Ireland, Germany and France

Yes, patients with Graves disease can safely start GLP-1 receptor agonists for diabetes or weight loss, as there are no specific contraindications related to...

B0DQ9X32KT

Glucagon-like peptide-1 (GLP-1) receptor agonists were touted as breakthrough drugsin 2023 and their popularity has soared since. More than 4 million items of tirzepatide and semaglutide were dispensed on the NHS in England in 2025/20261, while around2.5 million people each monthaccessed GLP-1s privately at the end of 2025, according to James Kingsland, chair of []

We are proud to share that Professor Jens Juul Holst from the Department of Biomedical Sciences has been awarded the Lipid Science Prize 2026 by the Camurus Lipid Research Foundation in Malm. Jens receives the prize in recognition of his groundbreaking discovery of the GLP1 hormone back in 1986 - a finding that laid the foundation for diabetes and weightloss medications used by millions worldwide